HK Stock MarketDetailed Quotes

01763 CIRC

Watchlist
  • 10.780
  • -0.220-2.00%
Market Closed Nov 15 16:08 CST
3.45BMarket Cap7.87P/E (TTM)

About CIRC Company

Since its establishment in 1983, China Tongfu has begun exploration and development in the field of nuclear technology applications. It has been deeply involved in the industry for 40 years, and is a leading domestic enterprise in this field. As a comprehensive strategic industry, the application of nuclear technology is closely related to nearly one-third of the manufacturing industry in the national economy, and plays an important role in scientific and technological innovation, economic construction, national health, and national security. With the continuous development of the Chinese economy and the steady improvement of people's living standards, the market demand for nuclear technology applications will continue to grow in the future, and China will also have more room for development. China focuses on research and development, production, and sales of pharmaceuticals, and also provides services for radiation sources, irradiation, nuclear medical equipment, and independent medical testing laboratories. 62.2% of the company's revenue and 83.0% of gross profit come from the pharmaceutical sector, which belongs to the nuclear medicine industry. The nuclear medicine industry is an industry with high potential, high threshold, and high profit. As a leading enterprise in China's nuclear medicine industry, China Tongfang is the largest domestic manufacturer of radiopharmaceuticals, urea breath test kits and testers, and radioimmunoassay kits for imaging diagnosis and treatment. In terms of radioactive source products, China Tongfang is the only domestic core enterprise with industrialized and large-scale R&D and production capabilities in the field of radioactive source research and application. In terms of irradiation, China Tongshui is the third largest irradiation processing service provider in China. It is the only supplier in China that provides upstream production and downstream design and installation services for irradiation devices. Its two subsidiaries are two of the three EPC service providers approved by China's Ministry of Ecology and Environment to design, manufacture, and install irradiation devices. As an important member unit of the CNNC Group in the field of nuclear technology application, China Tongfu has undertaken CNNC's deep accumulation in the fields of isotopes, radiopharmaceuticals, radiation sources, irradiation applications, etc. In future development, it will also further cooperate with other CNNC companies to make full use of CNNC's superior resources to better serve the national economy and help the high-quality development of nuclear technology applications.

Company Profile

Symbol01763
Company NameCIRC
ISINCNE1000031F4
Listing DateJul 6, 2018
Issue Price21.60
Shares Offered79.97M share(s)
FoundedJan 31, 1983
Registered AddressChina
Chairmanjunqi zhang
Secretarycangrenguanxiuyan wang
Audit InstitutionShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Company CategoryMainland registration of Mainland State-owned Assets control
Registered OfficeRoom 418, 4th Floor, South Floor, Building 1, No. 66 Changwa Middle Street, Haidian District, Beijing
Head Office and Principal Place of Business5th Floor, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees3132
MarketHong Kong motherboard
Phone(86)1068515220
Fax(86)1068512374
Emailir@ circ.com.cn
Business License items: pharmaceutical wholesale; drug import and export; sale of Class I radiation sources; sale of Class II, III, IV, and V radiation sources; sale of Class II and Class III radiation devices; management of class III medical devices; leasing of class III medical devices; sale of disinfection equipment. (Projects requiring approval according to law can only be carried out after approval by relevant departments. Specific business projects are subject to documents or licenses approved by relevant departments) General projects: Class I medical device sales; Class II medical device sales; Class II medical device leasing; customs clearance business; sales agency; electronic product sales; sales of communication equipment; sales of mechanical parts and components; sales of instruments; sales of special instruments for environmental monitoring; sales of experimental analytical instruments; sales of mechanical equipment; sales of automotive parts; sales of chemical products (excluding licensed chemical products); sales of disinfectants ( Excluding hazardous chemicals); sales of specialty chemical products (excluding hazardous chemicals); sales of bio-based materials; sales of metal materials; sales of office equipment and consumables; manufacturing of industrial textile products; sales of knitted textiles; sales of household goods; sales of labor protection products; sales of office supplies; sales of property management; conference and exhibition services; technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion. (With the exception of projects subject to approval according to law, business activities are carried out independently on the basis of a business license) (You may not engage in business activities prohibited or restricted by national and municipal industrial policies.)

Company Executives

  • Name
  • Position
  • Salary
  • junqi zhang
  • Chairman, Executive Director, General Manager, Strategy Committee Members
  • 354.00K
  • guomin fan
  • Executive Director, Deputy General Manager, Employee Representative Director
  • 1.02M
  • zan chen
  • Non-executive Directors, Strategy Committee Members, Audit Committee Members, Member of the Risk Management Committee
  • --
  • jianmin ding
  • Non-executive Directors, Strategy Committee Members
  • --
  • jinyu chang
  • Non-executive Directors
  • --
  • xiuhong liu
  • Non-executive Directors, Remuneration Committee Members
  • --
  • zhaoguo pan
  • Independent Non-Executive Director, Chairman of the Risk Management Committee, Chairman of the Audit Committee, Nomination Committee Members
  • 68.00K
  • jingshan chen
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members
  • 150.00K
  • chuang lu
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Member of the Risk Management Committee, Nomination Committee Members
  • 150.00K
  • zhonglin liu
  • Chairman of the Supervisory Board
  • --
  • nanfei zhao
  • Auditors
  • --
  • guoping zhang
  • Auditors
  • --
  • qihui peng
  • Employee Representative Supervisor
  • 536.00K
  • fuxin ma
  • Employee Representative Supervisor
  • 550.00K
  • jin du
  • Chief Engineer
  • 1.10M
  • youquan gui
  • Chief Accountant, General Counsel, Authorized Representative
  • --
  • li huang
  • Deputy General Manager
  • --
  • guoqing wang
  • Deputy General Manager
  • --
  • yongjiang han
  • Executive Director, Chairman of the Strategy Committee
  • --
  • rui an
  • Independent Non-Executive Director, Strategy Committee Members
  • --
  • cangren wang
  • Joint Company Secretary, Board Secretary, General Counsel, Authorized Representative
  • --
  • xiuyan guan
  • Joint Company Secretary, Legal Process Document Agent
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data